• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Real World Evidence (RWE)

Datavant & Boehringer Ingelheim Expand RWE Partnership for 75+ Clinical Trials

by Syed Hamza Sohail 05/05/2025 Leave a Comment

Datavant & Boehringer Ingelheim Expand RWE Partnership for 75+ Clinical Trials

What You Should Know: -  Datavant, a leading health data platform, has announced an expanded collaboration with Boehringer Ingelheim to strengthen the pharmaceutical company’s real-world evidence (RWE) capabilities. -  This partnership aims to advance clinical development and commercial strategy across 75 additional clinical trials and multiple new molecular entities (NMEs), leveraging Datavant’s cutting-edge privacy-preserving tokenization and data connectivity technologies. Datavant
Read More

Advancing Drug Development and Regulatory Compliance with AI-Enhanced Real-World Evidence

by Sujay Jadhav, Verana Health CEO 02/11/2025 Leave a Comment

Optimizing Clinical Trials with AI and Data-Driven Insights

In recent years, regulatory bodies, such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have increasingly emphasized the use of real-world data (RWD) in clinical research and regulatory decisions, recognizing its potential to enhance drug development and improve patient outcomes. This shift includes a focus on sourcing RWD that adheres to strict regulatory standards for effective use in drug approvals and postmarket surveillance.  Unlike traditional
Read More

Guardant Health and ConcertAI Partner to Unlock Cancer Insights with Multi-Modal Real-World Data

by Fred Pennic 01/17/2025 Leave a Comment

Guardant Health and ConcertAI Partner to Unlock Cancer Insights with Multi-Modal Real-World Data

What You Should Know:  - Guardant Health, a provider in precision oncology, and ConcertAI, a real-world evidence (RWE) and AI technology company in oncology, announced a strategic collaboration that will provide biopharmaceutical companies with access to a first-of-its-kind multi-modal real-world data (RWD) solution.  - The partnership integrates comprehensive patient electronic medical record (EMR) data with genomic and epigenomic tumor profiling information, offering a deeper
Read More

Optimizing Clinical Trials with AI and Data-Driven Insights

by Sujay Jadhav, CEO of Verana Health 11/25/2024 Leave a Comment

Optimizing Clinical Trials with AI and Data-Driven Insights

While most technology- and innovation-oriented industries have followed the general principles of Moore’s Law, which holds that computing power would double yearly, while costs were cut in half, the life sciences industry appears to be spending more money developing fewer drugs.  According to the latest data, the cost to take a drug candidate from the discovery stage, all the way to market launch, hit $2.3 billion in 2022—a $298 million rise from 2021. Meanwhile, there were
Read More

Verantos Launches Alzheimer’s Disease Pragmatic Registry to Support RWE Generation

by Syed Hamza Sohail 07/10/2024 Leave a Comment

Verantos Launches Alzheimer’s Disease Pragmatic Registry to Support RWE Generation

What You Should Know: - Verantos, the global leader in high-validity real-world evidence at scale, has launched its Alzheimer’s Disease Pragmatic Registry. - This registry offers life sciences organizations rich and reliable data on patients with Alzheimer’s disease and related conditions. Verantos: Leading High-Validity Real-World Evidence Verantos is the global leader in high-validity real-world evidence at scale. By applying artificial intelligence to comprehensive patient
Read More

Atropos Health Raises $33M to Improve Value-Based Care Through Real-World Evidence

by Syed Hamza Sohail 05/23/2024 Leave a Comment

Atropos Health Raises $30M to Improve Value-Based Care Through Real-World Evidence

What You Should Know: -       Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence for care, today announced a $33 million Series B on the heels of the adoption of its Generative AI platform (GENEVA OSTM) by healthcare institutions, data platforms, research institutions, Life Sciences companies and more. -       The funding was led by Valtruis, with participation from new strategic investors
Read More

Verantos Bolsters Real-World Data Network with 7M Patient Records from CuriMeta

by Fred Pennic 03/28/2024 Leave a Comment

Verantos Bolsters Real-World Data Network with 7M Patient Records from CuriMeta

What You Should Know: - Verantos, the leader in high-quality real-world evidence (RWE) forms a strategic partnership with CuriMeta to expand Verantos' Research Network with de-identified data from 7 million patients, - The collaboration will enhance the depth and reach of real-world data (RWD) available to life science organizations. Enhancing RWD Quality and Accessibility The Verantos Research Network is a unique platform that gathers data from various sources, including academic
Read More

Atropos Health and Google Cloud Partner to Turbocharge Real-World Evidence Generation for Healthcare Systems

by Jasmine Pennic 01/30/2024 Leave a Comment

Atropos Health and Google Cloud Partner to Turbocharge Real-World Evidence Generation for Healthcare Systems

What You Should Know: - Atropos Health, a leader in transforming real-world clinical data into personalized insights, today announced a game-changing collaboration with Google Cloud. - The partnership optimizes Atropos' GENEVA OS platform to seamlessly integrate with Google Cloud's Healthcare Data Engine (HDE) and BigQuery, empowering healthcare systems to unlock the full potential of their data. By simplifying data access, streamlining analytics, and democratizing insights, this
Read More

Syapse and FDA OCE Collaborate to Advance Real-World Evidence in Oncology

by Jasmine Pennic 12/05/2023 Leave a Comment

Syapse and FDA OCE Join Forces to Elevate Real-World Evidence in Oncology

What You Should Know: - Syapse®, a leading real-world evidence (RWE) company dedicated to extinguishing the fear and burden of serious diseases, and the FDA Oncology Center of Excellence (OCE) today announced the renewal of their four-year collaboration agreement. - This expanded strategic partnership aims to collaboratively develop and implement research projects that advance the use of real-world data (RWD) and explore the potential of RWE to inform regulatory decisions in
Read More

Inovalon & HealthVerity Partner to Advance Real-World Evidence

by Jasmine Pennic 10/18/2023 Leave a Comment

What You Should Know:  - Inovalon, a provider of cloud-based software solutions empowering data-driven healthcare, today announced the establishment of a Preferred Data Partner Program.  - The program aims to work with a select number of leading organizations that are committed to the thoughtful application of data towards the improvement of economics and outcomes across the healthcare ecosystem. HealthVerity Partnership With the establishment of this program, Inovalon is
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 5
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |